» Articles » PMID: 29515996

Exosome-Based Cell-Cell Communication in the Tumor Microenvironment

Overview
Specialty Cell Biology
Date 2018 Mar 9
PMID 29515996
Citations 335
Authors
Affiliations
Soon will be listed here.
Abstract

Tumors are not isolated entities, but complex systemic networks involving cell-cell communication between transformed and non-transformed cells. The milieu created by tumor-associated cells may either support or halt tumor progression. In addition to cell-cell contact, cells communicate through secreted factors via a highly complex system involving characteristics such as ligand concentration, receptor expression and integration of diverse signaling pathways. Of these, extracellular vesicles, such as exosomes, are emerging as novel cell-cell communication mediators in physiological and pathological scenarios. Exosomes, membrane vesicles of endocytic origin released by all cells (both healthy and diseased), ranging in size from 30 to 150 nm, transport all the main biomolecules, including lipids, proteins, DNAs, messenger RNAs and microRNA, and perform intercellular transfer of components, locally and systemically. By acting not only in tumor cells, but also in tumor-associated cells such as fibroblasts, endothelium, leukocytes and progenitor cells, tumor- and non-tumor cells-derived exosomes have emerged as new players in tumor growth and invasion, tumor-associated angiogenesis, tissue inflammation and immunologic remodeling. In addition, due to their property of carrying molecules from their cell of origin to the peripheral circulation, exosomes have been increasingly studied as sources of tumor biomarkers in liquid biopsies. Here we review the current literature on the participation of exosomes in the communication between tumor and tumor-associated cells, highlighting the role of this process in the setup of tumor microenvironments that modulate tumor initiation and metastasis.

Citing Articles

Exosomal-complement system activation in preeclampsia.

David M, Maharaj N, Krishnan A J Obstet Gynaecol Res. 2025; 51(3):e16255.

PMID: 40070019 PMC: 11897585. DOI: 10.1111/jog.16255.


Current challenges surrounding exosome treatments.

Tzng E, Bayardo N, Yang P Extracell Vesicle. 2025; 2:100023.

PMID: 40027080 PMC: 11870656. DOI: 10.1016/j.vesic.2023.100023.


The role of exosomal non-coding RNAs in the breast cancer tumor microenvironment.

Saadh M, Allela O, Kareem R, Ballal S, Chahar M, Saini S Funct Integr Genomics. 2025; 25(1):32.

PMID: 39891771 DOI: 10.1007/s10142-025-01531-2.


Developing anti-TDE vaccine for sensitizing cancer cells to treatment and metastasis control.

Meena S, Kosgei B, Soko G, Tingjun C, Chambuso R, Mwaiselage J NPJ Vaccines. 2025; 10(1):18.

PMID: 39870669 PMC: 11772600. DOI: 10.1038/s41541-024-01035-3.


Exosomes: Key Messengers Mediating the Interaction Between Tumor Cells and CD8 T Cells in the Tumor Microenvironment.

Li Y, Yang Q, Li D, Li W, Men W Int J Nanomedicine. 2025; 20():653-667.

PMID: 39835179 PMC: 11745065. DOI: 10.2147/IJN.S502363.


References
1.
Zhou M, Chen J, Zhou L, Chen W, Ding G, Cao L . Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cell Immunol. 2014; 292(1-2):65-9. DOI: 10.1016/j.cellimm.2014.09.004. View

2.
Pan L, Liang W, Fu M, Huang Z, Li X, Zhang W . Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression. J Cancer Res Clin Oncol. 2017; 143(6):991-1004. DOI: 10.1007/s00432-017-2361-2. View

3.
Yang C, Chalasani G, Ng Y, Robbins P . Exosomes released from Mycoplasma infected tumor cells activate inhibitory B cells. PLoS One. 2012; 7(4):e36138. PMC: 3338602. DOI: 10.1371/journal.pone.0036138. View

4.
Czystowska M, Szczepanski M, Szajnik M, Quadrini K, Brandwein H, Hadden J . Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic. Cancer Immunol Immunother. 2010; 60(4):495-506. PMC: 3708464. DOI: 10.1007/s00262-010-0951-9. View

5.
Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L . Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res. 2010; 70(17):6945-56. DOI: 10.1158/0008-5472.CAN-10-0785. View